Fairfield, Bush & Co. Mimedx Group, Inc. Transaction History

Fairfield, Bush & Co.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$5.7 - $9.14 $43,616 - $69,939	7,652 New	7,652 $67.1 Million
Q2 2023 Aug 15, 2023	BUY	$3.14 - $6.61 $24,027 - $50,579	7,652 New	7,652 $50.6 Million
Q2 2022 Aug 09, 2022	SELL	$3.17 - $5.0 $1,902 - $3,000	-600 Reduced 7.23%	7,700 $27,000
Q1 2022 May 06, 2022	SELL	$4.27 - $6.27 $32,024 - $47,025	-7,500 Reduced 47.47%	8,300 $39,000
Q4 2021 Feb 09, 2022	SELL	$5.7 - $8.48 $17,100 - $25,440	-3,000 Reduced 15.96%	15,800 $95,000
Q3 2021 Nov 08, 2021	BUY	$5.52 - $15.83 $103,775 - $297,604	18,800 New	18,800 $114,000

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.03B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.